BCIQ Profiles

Company Profile ReportTarget Profile Report

Eureka reports Phase I response data for anti-CD19 T cell therapy in lymphoma

Eureka Therapeutics Inc. (Emeryville, Calif.) reported preliminary data from 17 evaluable patients with CD19-positive, relapsed and

Read the full 168 word article

How to gain access

Continue reading with a
two-week free trial.